semaglutide 0.25 0.5mg/dose pen device Generic mg / 0.5 mg behavior change Ozempic 0.25 mg, 0.5 mg

Pharmacists: screen meds for promotors of ileus/pseudo-obstruction, ensure neostigmine dosing, check bradycardia/bronchospasm risks, prepare atropine and resuscitation drugs, and document plans for restarting opioids or anticholinergic drugs only after resolution

Daily dosing also allows clinicians to identify tolerability early and make timely changes to the medication plan if needed

It has not received a marketing authorisation from the MHRA, nor has it been granted approval by the EMA

Funding There was no direct funding for this work, and the authors report no disclosures relevant to the manuscript

MOTS-c Storage & Handling Storage temperatures and stability State Lyophilized (Powder Form) Storage -4F (-20C) long-term Notes Refrigerator (36-46F / 2-8C) is acceptable short-term per supplier label and stability data